Grace Therapeutics
GRCE
#10485
Rank
A$55.55 M
Marketcap
A$2.64
Share price
1.66%
Change (1 day)
-44.45%
Change (1 year)

Annual Reports (40-F)

Latest form 40-F annual reports for Grace Therapeutics CIK: 0001444192
The 40-F is the annual report that Canadian companies file with the SEC instead of a 10-K. It contains the annual information form, MD&A and financial statements of Grace Therapeutics

Thumbnail Grace Therapeutics 40-F Annual Report 2013

40-F Annual Report 2013

Language: English

View Annual Report (40-F)